ACOG Releases New Guidance on the Use of GLP-1s in Pregnancy and Lactation
American College of Obstetricians and Gynecologists (ACOG) shared on LinkedIn:
“Today ACOG released new guidance to help ob-gyns counsel patients on the use of GLP-1 medications before, during, and after pregnancy, given the lack of sufficient data around GLP-1 usage and pregnancy-related outcomes.
We recommend that ob-gyns counsel their patients on the limited safety data available and advise their patients to consider stopping GLP-1 medications one to two months before becoming pregnant. Ob-gyns should tell patients that it’s unclear how taking GLP-1 medications in the postpartum period could affect lactation and make shared decisions that consider factors such as limited data, medication specifics, and the needs of the patient and infant.
Read the full press release.”
Other articles featuring ACOG on Fertility News.
-
Oct 23, 2026, 17:34Breast Cancer Awareness Month: Supporting Women Through Every Journey – Egg Donor and Surrogate Solutions
-
Oct 23, 2026, 17:28Demián Glujovsky: What Happens to Fertility Patients Between Visits?
-
Oct 23, 2026, 17:21Stephen Parker Ellington: Empathetic Fertility Care Can Scale, Even When Your Team Can’t
-
Oct 23, 2026, 17:06Emad Sedeek: ESHRE Recommendations on Good Practice in the IVF Laboratory 2026 – Part 2
-
Oct 23, 2026, 16:59Nitiz Murdia: Guiding You Through IVF – Your Journey’s Pilot
-
Oct 23, 2026, 16:56Ben Peipert: Come See My Poster Presentation at ASRM 2026
-
Oct 23, 2026, 16:50New RBMO Review Examines Benefits and Risks of Freeze-All IVF Strategies Across Ovarian Response Groups
-
Oct 23, 2026, 16:381 Week and Counting to the Next Campus Course on Male Infertility – ESHRE
-
Oct 23, 2026, 16:34Lynn Mason: Taking Our Research at ASRM Beyond the Conference and Into Patient Care